Articles

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

17.12.2014 BE law

Team

Related news

24.10.2019 BE law
Virtual Currency Regulation Law Review - Belgian chapter

Articles - The second edition of the Virtual Currency Regulation Law Review is intended to provide a practical, business-focused analysis of recent legal and regulatory changes and developments, and of their effects, and to look forward at expected trends in the area of virtual currencies on a country-by-country basis.

Read more

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring